Salarius Pharmaceuticals ... (SLRX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
2.55
-0.09 (-3.41%)
At close: Jan 15, 2025, 3:59 PM
2.69
5.49%
After-hours Jan 15, 2025, 04:37 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
PE Ratio | -1.35K | -0.83 | -12.91 | -15.98 | -17.62 | -2.17 | -14 | -17.36 | -47.96 | n/a |
PS Ratio | n/a | n/a | 89.12 | 21.67 | 28.53 | 56.76 | 377.97 | 678.25 | n/a | n/a |
PB Ratio | 3.21 | 2.50 | 4.24 | 5.12 | 9.34 | 5.12 | 16.56 | 11.56 | 15.16 | n/a |
P/FCF Ratio | -1.32 | -1.36 | -16.08 | -11 | -8.54 | -2.02 | -17.31 | -21.03 | -66.52 | n/a |
P/OCF Ratio | -1.32 | -1.48 | -16.08 | -11 | -8.54 | -2.02 | -17.38 | -21.39 | -67.37 | n/a |
OCF/S Ratio | n/a | n/a | -5.54 | -1.97 | -3.34 | -28.16 | -21.74 | -31.7 | n/a | n/a |
Debt / Equity Ratio | 0.05 | n/a | n/a | 0.02 | 0.05 | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 5.02 | 3.78 | 14.29 | 5.70 | 1.42 | 9.15 | 5.79 | 15.91 | 33.50 | 34.40 |
Current Ratio | 5.02 | 3.40 | 14.29 | 5.70 | 1.42 | 9.32 | 5.87 | 16.03 | 33.50 | 34.40 |
Asset Turnover | n/a | n/a | 0.05 | 0.21 | 0.25 | 0.08 | 0.04 | 0.02 | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | -2.56K | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity (ROE) | -0.00 | -3.02 | -0.33 | -0.32 | -0.53 | -2.36 | -1.18 | -0.67 | -0.32 | n/a |
Return on Assets (ROA) | -0.00 | -2.14 | -0.31 | -0.28 | -0.4 | -2.11 | -0.98 | -0.62 | -0.31 | n/a |
Return on Capital (ROIC) | -0.00 | -3.07 | -0.33 | -0.35 | -0.91 | -2.38 | -1.19 | -0.67 | -0.32 | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | -0.02 | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 98.96% | 99.87% | 99.88% | 48.57% | 60.24% | 34.42% | n/a | n/a |
Net Profit Margin | n/a | n/a | -690.37% | -135.61% | -161.88% | -2.62K% | -2.70K% | -3.91K% | n/a | n/a |
Pretax Profit Margin | n/a | n/a | -693.84% | -140.49% | -200.23% | -2.62K% | -2.70K% | -3.91K% | n/a | n/a |
Operating Profit Margin | n/a | n/a | -696.27% | -148.78% | -276.37% | -2.63K% | -2.72K% | -3.95K% | n/a | n/a |
FCF Margin | n/a | n/a | -554.29% | -197.08% | -334.2% | -2.82K% | -2.18K% | -3.23K% | n/a | n/a |
EBITDA Margin | n/a | n/a | -692.8% | -140.09% | -199.74% | -2.63K% | -2.68K% | -3.95K% | n/a | n/a |